M ycobacterium tuberculosis, the etiological agent of tuberculosis (TB), is one of the most successful human pathogens and has acquired the ability to establish latent or progressive infection and persists despite the presence of a fully functioning innate and acquired immune system (1) . M. tuberculosis may infect susceptible individuals causing primary TB, a usually mild disease that in most cases is controlled by the development of an efficient immune response, even when mycobacteria are not completely cleared (2) . Rather, it is supposed that the immune response forces M. tuberculosis to shift into a dormant nonreplicating status causing a latent TB infection (LTBI) (3, 4) .
However, concomitant diseases, acquired immunodeficiencies (5), or treatments with immunosuppressive drugs may facilitate M. tuberculosis reactivation (6) causing postprimary TB, a severe disease that has a chronic and often fatal course in the absence of adequate treatment (7) .
Despite the mechanisms of immune evasion that M. tuberculosis has evolved, a robust immune response may be measured in both active disease and LTBI, with the exception of advanced stages of active diseases that are characterized by anergic T cell responses (8) . However, the host immune response may represent a double-edged sword in different TB stages: it has certainly a protective role, but it may also be detrimental to the host and instrumental to M. tuberculosis to infect other individuals (9) . The immune response also contributes to causing tissue damage, caseum liquefaction (10) , and eventually the formation of cavities merging into the bronchial tree. These open lesions permit the communication between TB foci and the external environment, thus making it possible for M. tuberculosis to diffuse in the environment by droplets.
In active disease, M. tuberculosis mainly infects professional phagocytes in the lungs where it uses strategies such as prevention of phagolysosome maturation, subversion of host cell death pathways, and the immune system to survive and replicate (11, 12) . In LTBI, M. tuberculosis is thought to survive in a dormant, nonreplicating form supposedly confined in storage cells in lung and other organs (13, 14) of asymptomatic individuals, where it may persist for years. Dormant M. tuberculosis (D-Mtb) may be cultured in vitro where it has been shown to be resistant to adverse conditions, as it survives high hypoxia or nutrient deprivation (15, 16) . D-Mtb undergoes extensive transcriptional changes that are triggered by hypoxia and a variety of other conditions including environmental cues through the DevR transcription factor. The DevR transcription factor controls the upregulation of a subset of genes with a wide variety of functions, including general protection, lipid metabolism, and anaerobic respiration (17) . The shift to dormancy is also associated to downregulation of a variety of genes that could, in principle, affect its immunogenicity or capacity to escape immune recognition (18) .
Interestingly, morphologic and transcriptome analysis of M. tuberculosis in sputum of infected individuals revealed the presence of high percentages of D-Mtb in active TB (19) . Moreover, a resuscitation-promoting factor-dependent population of M. tuberculosis was recently observed in clinical TB samples, providing further evidence of the presence of D-Mtb in sputa (20) . Because sputa of infecting individuals are likely to reflect the population of bacilli present in open TB lung lesions (19) , these data suggest that a large population of D-Mtb can be found in active TB lesions and that dormant bacteria are not necessarily only associated to latency. The analysis of the M. tuberculosis population in sputa also supports the hypothesis that D-Mtb may be transmitted to susceptible individuals through the infecting droplets released from patients with active TB. To date, no data are available on the interactions of D-Mtb with the immune system. Such interactions could have important functional consequences not only in latent infections, but also in primary and postprimary TB. In this study we monitored the consequence of macrophage infection by D-Mtb or replicating M. tuberculosis (RMtb) and the resulting Ag-specific T cell activation.
Materials and Methods

Reagents
RPMI 1640 (Euroclone, Devon, U.K.) was used supplemented with 1 mM L-glutamine, 1 mM sodium pyruvate, 1% nonessential amino acids, and 10% FBS (Hyclone, Logan, UT) (complete medium, CM).
M-CSF, GM-CSF, recombinant human IL-4, and recombinant human IL-2 were purchased from R&D Systems (Minneapolis, MN). LPS from Escherichia coli 055:B5, BSA chloroquine, methylene blue, and propidium iodide were purchased from Sigma-Aldrich (St. Louis, MO), and bafilomycin A1 was from Santa Cruz Biotechnology (Santa Cruz, CA). Recombinant MP65 was a gift of Dr. R. La Valle, purified protein derivative (PPD) was from Statens Serum Institut (Copenhagen, Denmark), LysoTracker Red DND-99 and probe dye-quenched BSA (DQ-BSA) were from Molecular Probes, auramine was from Becton Dickinson, PHA (HA-16) was from Murex Diagnostics, and the Bio-Rad protein assay kit was from Bio-Rad (Hercules, CA).
Growth of mycobacteria
M. tuberculosis H37Rv (ATCC 27294) was used for all experiments. Aerobic bacteria were grown in agitation in Dubos Tween-albumin broth (Difco, Detroit, MI) and collected at the midlog phase, that is, OD 600 of 0.4. D-Mtb was generated as previously described (21) (22) (23) . Briefly, hypoxic bacteria were grown by stirring (120 rpm) in sealed glass tubes containing Dubos Tween-albumin broth and incubated for 25 d at 37˚C. This stage corresponds to late nonreplicating persistence phase 2, after the induction of the dormancy regulon and the enduring hypoxic response gene subsets (17, 21) . Control tubes with 1.5 mg/ml methylene blue as an indicator of oxygen depletion were included. The cultures were centrifuged at 3000 rpm for 30 min, washed three times in RPMI 1640, and resuspended in RPMI 1640 containing 10% FBS, and aliquots of both forms of M. tuberculosis were immediately frozen at 280˚C until use. To infect cells with the same number of D-Mtb and R-Mtb, two aliquots of both mycobacteria were then thawed and CFU counts were performed in agar plates. Briefly, determination of bacterial CFU was performed by plating serial dilution of D-Mtb or R-Mtb aliquots on Middlebrook 7H10 agar (Difco) supplemented with 10% oleic acid-albumin-dextrose-catalase enrichment (Difco). Colonies were counted after 21 d of growth at 37˚C and 5% CO 2 . This procedure allows us to define the number of mycobacteria in the respective aliquots with the best accuracy provided by currently available methods. In fact, samples of both D-Mtb and R-Mtb prepared for 3:1 multiplicity of infection (MOI) were shown to contain comparable amounts of total DNA (measured by quantitative PCR using 16S specific primers), and the protein content measured by colorimetric Bradford assay (Bio-Rad) on equivalent CFU counts of D-Mtb and R-Mtb indicated a slightly reduced protein content in extracts from D-Mtb compared with R-Mtb, and thus the presence of noncountable dead mycobacteria in D-Mtb preparations could be excluded. As a consequence, all the infection experiments were performed at the indicated MOI using aliquots containing comparable amounts of viable mycobacteria. For some experiments, both R-Mtb and D-Mtb were heat-killed (HK) at 80˚C for 1 h. All M. tuberculosis preparations were analyzed for LPS contamination by the Limulus lysate assay (BioWhittaker, Verviers, Belgium) and contained ,10 pg/ml LPS.
RNA extraction and quantitative RT-PCR
Bacterial cultures were centrifuged and pellets resuspended in TRIzol reagent (Invitrogen, Carlsbad, CA), transferred to a new tube containing 500 ml 0.1 mm zirconia/silica beads (BioSpec Products, Bartlesville, OK), and passed through six cycles of 50 s each at maximum speed using a MiniBeadbeater-8 (BioSpec Products). Total RNA was then purified with an SV Total RNA Isolation System (Promega, Madison, WI) and DNase treated before reverse transcription in a final volume of 20 ml using 1 ml ImProm-II reverse transcriptase (Promega) in ImProm-II reaction buffer containing 0.5 mM 29-deoxynucleoside 59-triphosphate and 3 mM MgCl 2 . Quantitative real-time PCR from D-Mtb cDNA was performed in an iCycler iQ (Bio-Rad) with iQ SYBR Green Supermix (Bio-Rad) and 500 nM each primer for 40 cycles as follows: 40 s at 95˚C, 40 s at 59˚C, and 50 s at 72˚C for 40 cycles. Primer sequences were previously described (21) . Data were expressed according to the DDCt method by using day 3 cDNA as the reference time point. All reactions were performed in triplicate, and all RNAs were tested for the absence of genomic DNA contamination using quantitative PCR.
Monocyte isolation, macrophage and dendritic cell generation, and infection
This study was approved by the Istituto Superiore di Sanità Review Board, and written informed consent was obtained by the healthy volunteers who participated in the study. PBMC from healthy donors were isolated by Ficoll density gradient. Monocytes were then positively sorted using anti-CD14-labeled magnetic beads (MACS; Miltenyi Biotec, Bergisch Gladbach, Germany) and resuspended in RPMI 1640-based CM. Macrophages and dendritic cells (DC) were generated culturing monocytes in CM containing 50 ng/ml M-CSF for 6 d or 50 ng/ml GM-CSF and 1000 U/ml IL-4 for 5 d, respectively (24) . Differentiated cells were infected with M. tuberculosis at MOIs ranging from 1:1 to 10:1 and the MOI of 3:1 was used unless otherwise indicated for overnight (o/n) incubation. In some experiments, HK mycobacteria were used to treat macrophages at the ratio of 3:1. Where indicated, LPS at 0.1 mg/ml was added as positive control the sixth day of culture to induce macrophage or DC activation.
The viability of macrophages and DC after infection with D-Mtb or RMtb was evaluated by flow cytometry using the Live/Dead fixable dead cell stain kits (Invitrogen), an assay based on the reaction of a fluorescentreactive dye with cellular amines. Cells were infected (MOI of 1:1 and 3:1) with bacteria o/n and then incubated up to 3 d. Cells were then stained with fluorescent-reactive dye (0.5 mM, 30 min at room temperature), fixed o/n with 4% paraformaldehyde, and finally analyzed by flow cytometry. No significant difference in viability between D-Mtb-or R-Mtb-infected macrophages or DC was observed in the 3 d of culture.
Phagocytosis assays
Infection of human macrophages with D-Mtb or R-Mtb was assessed by counting intracellular mycobacteria in cells stained with the Kinyoun method, and the efficiency of infection was quantitated by counting the CFU. Macrophages were infected with D-Mtb or R-Mtb (MOI of 1:1) for 1 h and then cultured o/n in the presence of kanamycin (100 U/ml) to kill extracellular mycobacteria. Cells were washed three times using warm RPMI 1640 to remove antibiotics and noninternalized mycobacteria and lysed immediately or after an additional 1, 3, or 6 d culture. Lysis was performed using distilled water containing 0.1% saponin for 5 min at room temperature. For CFU counts, cell lysates were briefly sonicated and 10-fold dilutions were performed using 0.05% Tween 80 in distilled water before plating on Middlebrook 7H10. After 21 d incubation at 37˚C in 5% CO 2 atmosphere, CFU in each plate were enumerated.
FACS analysis
Infected APC were collected and stained for 30 min at 4˚C with the following mAbs: anti-HLA class I, HLA-DR class II, CD40, CD80, CD83, CD86, and CCR7 or appropriate isotype controls (all from BD Pharmingen). Then, stained cells were fixed o/n with 4% paraformaldehyde and analyzed using a FACScan cytometer equipped with CellQuest software (Becton Dickinson) acquiring 2 3 10 4 events gated according to macrophage or DC forward and size scatters.
Staining of acidic vesicles and analysis of proteolytic capacity
LysoTracker Red DND-99 is a fluorescent acidotropic probe that accumulates in lysosomes and is used for the staining and semiquantitative evaluation of acidic intracellular organelles by FACS. Macrophages were infected or treated with viable or HK bacteria, respectively, for 7, 24, or 48 h and then incubated with LysoTracker Red DND-99 probe (0.5 mM, 20 min at 37˚C) followed by fixation with 4% paraformaldehyde o/n. Then cells were analyzed by flow cytometry collecting FL2 fluorescence. Untreated and unstained cells and cells treated with bafilomycin A1 (50 nM) were used as controls to set the background fluorescence. To measure by flow cytometry the proteolytic capacity of phagosomes, macrophages were infected or treated with viable or HK bacteria, respectively, for 6, 24, or 72 h and then incubated with DQ-BSA as specified by the manufacturer. Cells treated with chloroquine (50 mM) served as a control to set the background fluorescence. Cells were then fixed with 4% paraformaldehyde o/n and analyzed by flow cytometry collecting FL4 fluorescence.
Confocal microscopy
Monocytes (4 3 10 5 /ml) were allowed to differentiate into macrophages on glass coverslips (12 mm For confocal analysis of acidic intracellular organelles, adherent macrophages infected or treated with viable or HK bacteria, respectively, were cultured for 48 h. Macrophages were then washed in PBS and incubated with LysoTracker Red DND-99 (0.5 mM, 20 min at 37˚C) before fixation with 4% paraformaldehyde o/n.
After gentle washing with PBS, the coverslips were mounted in buffered 1:1 (v/v) PBS-glycerine solution on prewashed slides.
Confocal laser scanning microscopy analysis was performed by using 488-nm excitation wavelength for direct auramine staining and 549-nm excitation wavelength for LAMP-1, vATPase, or LysoTracker Red DND-99. Emission lines were collected after passage through a DD488/543 filter in a spectral window ranging from 515 to 700 nm. Signals from different fluorescent probes were taken in sequential scan mode, allowing the elimination of channel crosstalk, and colocalization was detected in an overlay model. Images were processed by using LCS software (Leica Microsystems).
Quantitation of colocalization of mycobacteria with LAMP-1 and vATPase was performed by counting the green (noncolocalized) and yellow spotted (colocalized) mycobacteria up to 300 in processed merged images, considering occasional clumps as one Mycobacterium when displaying the same color.
Cytokine determination
Supernatants were collected after o/n incubation of APC with mycobacteria and frozen until use. IL-6, IL-8, IL-1b, and TNF-a were measured by ELISA using commercially available kits (R&D Systems Europe). Supernatants from the Ag presentation assays were collected after 48 h culture and evaluated for IFN-g production by ELISA (R&D Systems Europe). ELISAs were performed according to the manufacturer's instructions, and cytokine levels were expressed in picograms per milliliter. Detection limit of the assays was 15 pg/ml.
Ag-specific human CD4
+ T lymphocytes PPD-and MP65-specific MHC class II-restricted human CD4 + T cell clones (TCC) were isolated from a Mycobacterium bovis bacillus Calmette-Guérin (BCG)-vaccinated subject as previously described (24, 25) .
Clones were restimulated with PHA in the presence of recombinant human IL-2 (R&D Systems) and irradiated PBMC as feeder and cultured for 15-20 d. TCC were then washed twice to remove IL-2, counted, and resuspended in CM. One MP65-specific clone and seven PPD-specific TCC (RNPD3, RNPD36, RNPD49, RNPD50, RNPD73, RNPD130, and RNPD140) were used in this study.
Ag presentation assays
Macrophages or DC isolated from the same donor of TCC were plated into 96-well flat-bottom plates (20 3 10 3 cells/well) and infected or not with different MOI of D-Mtb or R-Mtb. After o/n incubation, PPD-specific TCC were added (30 3 10 4 cells/well) and supernatants were examined for IFN-g production by ELISA after 48 h culture. In some experiments, after o/n incubation, infected and noninfected autologous macrophages were pulsed with 10 mg/ml MP65 for 2 h. Then, an MP65-specific TCC (30 3 10 4 cells/ well) was added and IFN-g release was measured after 48 h coculture. Where indicated, the macrophages were treated o/n with HK bacteria.
Statistical analysis
All the statistical analyses were performed using the fourth version of GraphPad Prism software. The data were analyzed using the nonparametric Mann-Whitney U test. All tests for statistical significance were two-tailed and p values ,0.05 were considered significant.
Results
Growth characteristic and capacity to infect human macrophages of D-Mtb and R-Mtb
The growth of D-Mtb, produced in vitro as previously described (21) according to the Wayne model (22, 23) , was monitored by OD of the D-Mtb culture. After an initial growth, D-Mtb reached a stationary phase that persisted up to day 40. OD increased during the early phase and was arrested as the conditions became hypoxic, with bacteria entering nonreplicating persistence phase 1 (Fig. 1A) . In parallel, dosR regulon induction was monitored by RT-PCR. Fig. 1B shows that D-Mtb upregulates a-crystallin (hspX) gene expression (26) , which peaked around day 9 and dropped to levels characteristic of late nonreplicating persistence phase 2 stages (17) at day 25. In contrast, esat6 gene expression was progressively downregulated in D-Mtb.
To test whether the different metabolic state of M. tuberculosis influences the capacity to infect host cells, macrophages were infected at different MOI of D-Mtb or R-Mtb, and the percentage of infected cells was evaluated after o/n infection as well as the number of infecting mycobacteria after culture in the presence of antibiotics and lysis of macrophages to count the effective numbers of intracellular M. tuberculosis. Results indicate that D-Mtb and RMtb infect the same percentage of macrophages as measured by phase-contrast light examination after acid-fast Kinyoun staining (Fig. 1C) . Moreover, CFU counting of intracellular mycobacteria after overnight infection and lysis of macrophages (Fig. 1D) confirmed that D-Mtb and R-Mtb share the same ability to infect human macrophages. Of note, in the first 6 d after infection D-Mtb remained nonreplicating in infected macrophages (Fig. 1E) , confirming previous data obtained with infected THP1 cells (21) .
D-Mtb induces the activation of PPD-specific human TCC more efficiently than does R-Mtb
To test the immunogenicity of D-Mtb, we used a set of PPDspecific human CD4 + TCC previously generated from a BCGvaccinated donor (24) and studied the TCC capacity to proliferate and release IFN-g in response to autologous macrophages infected with D-Mtb or R-Mtb. From our panel of PPD-specific human CD4 + TCC, we selected seven TCC that were able to recognize Ag when autologous macrophages were infected with BCG. In an initial screening, we noticed that D-Mtb-infected macrophages constantly stimulated specific TCC with higher efficiency than did R-Mtb-infected macrophages (Fig. 2A) .
The same result was also obtained using macrophages infected with different MOI of D-Mtb or R-Mtb (Fig. 2B) . In fact, at all the MOI tested, D-Mtb-infected macrophages induced a stimulation of specific TCC, measured as IFN-g secretion, higher than macrophages infected with R-Mtb. The increased capacity of D-Mtb to activate specific T lymphocytes in comparison with R-Mtb was also observed using different APC, such as DC (Fig. 2C) . However, because the TCC we used are specific for PPD, which is a complex mixture of M. tuberculosis Ags, it is not possible to define the precise epitope recognized by individual clones. Therefore, because we could demonstrate that macrophages are infected with the same efficacy by the two forms of M. tuberculosis (Fig. 1C, 1D) , the results may indicate that 1) D-Mtb expresses increased amounts of the Ag recognized by our clones in comparison with R-Mtb, 2) the two forms of M. tuberculosis induce a different expression of APC stimulatory and costimulatory molecules, or 3) D-Mtb is processed and presented with a higher efficiency than R-Mtb by infected APC.
To test these hypotheses, we first treated the same macrophage population with HK bacteria. As killed bacteria cannot vary the amount of Ag by synthesis or degradation, the activation of TCC is reasonably dependent on the amount of Ag load delivered by dead bacteria into APC. Results clearly show that macrophages treated with HK D-Mtb or HK R-Mtb equally activate TCC (Fig. 2D) . Data indicate that 1) the tested TCC recognize epitopes shared by both forms of M. tuberculosis, and 2) the recognized peptides derive from the processing of protein Ags expressed at similar amounts in D-Mtb and R-Mtb.
D-Mtb and R-Mtb similarly activate human APC
It is well known that one of the mechanisms developed by M. tuberculosis to elude the immune system is by interfering with MHC class II molecule expression and with the activation of infected APC (11) . Interestingly, D-Mtb caused a reduction of the MHC class II molecule expression on APC, but the extent of reduction was comparable to that caused by R-Mtb (Fig. 3A-C) . Alternatively, neither D-Mtb nor R-Mtb interfered significantly with the expression of MHC class I molecules on APC (data not shown). To test whether infection with D-Mtb or R-Mtb induces different expression of costimulatory molecules on APC, we measured the membrane expression levels of CD80, CD86, and CD40 on macrophages (Fig. 3D) and CD80, CD86, CD83, and CCR7 expression on DC (Fig. 3E) . Results indicate that infection with D-Mtb or R-Mtb caused a similar upregulation of the costimulatory molecules on both macrophages and DC. Data suggest that D-Mtb-infected APC do not activate specific TCC with a higher efficiency than do R-Mtb-infected APC as a consequence of an augmented expression of costimulatory molecules. Accordingly, the activation of macrophages and DC following infection with D-Mtb or R-Mtb caused the secretion of comparable amounts of IL-6, IL-8, and TNF-a (Table I) . Of note, D-Mtb induced macrophages to secrete significantly lower amounts of IL1b in comparison with R-Mtb, suggesting that D-Mtb has a reduced capacity to activate macrophage inflammasomes.
D-Mtb does not interfere with the phagosome maturation and the protein processing functions of infected macrophages
One of the earliest virulence traits described for R-Mtb was its ability to block the phagolysosome maturation in infected macrophages. To test whether D-Mtb shares this capacity with R-Mtb, we analyzed phagosome/lysosome fusion in D-Mtb-or R-Mtbinfected human macrophages by confocal laser scanning microscopy. Infected macrophages were stained for the lysosomal marker protein LAMP-1, and M. tuberculosis was stained with auramine. 1) for 1 h and then cultured o/n in the presence of kanamycin (100 U/ml) to kill extracellular mycobacteria. Cells were washed three times using warm RPMI 1640 to remove antibiotics and noninternalized mycobacteria and cultured for 1, 3, or 6 days. For CFU counts, at the end of the indicated culture period, macrophages were lysed using distilled water containing 0.1% saponin for 5 min at room temperature and then plated on Middlebrook 7H10 as specified in Materials and Methods. After 21 d incubation at 37˚C in 5% CO 2 atmosphere, CFU in each plate were enumerated. (C)-(E) report means 6 SEM of data obtained from two independent experiments.
Confocal microscopy confirmed that both D-Mtb and R-Mtb were internalized by macrophages, because auramine staining was observed in intracellular layers (Fig. 4A) by Z scanning. More interestingly, confocal microscopy showed that most D-Mtb colocalized with LAMP-1, whereas most R-Mtb were found in the LAMP-1 2 compartments (Fig. 4A) . Some D-Mtb cells were observed to colocalize with LAMP-1 already at 6 h after the infection, and colocalization reached the highest frequency at 24 h after the infection and remained stable at 72 h, when some D-Mtb cell degradation was observed. Most R-Mtb was found in cellular compartments not expressing LAMP-1 at all the tested times (Fig. 4A) . Previous studies showed that R-Mtb is capable of increasing the phagosome pH by mechanisms involving the exclusion of the vATPase from the phagosomal membrane (27) . In agreement with previous data, confocal microscopy showed most R-Mtb in compartments where vATPase was excluded (28) . Conversely, D-Mtb was found colocalized with vATPase with a frequency that increased in the time course of infection (Fig. 4B) similarly to HK R-Mtb (Supplemental Fig. 1) . We then monitored the phagosomal acidity using LysoTracker Red, a dye whose fluorescence measures acidic vesicles (29) by flow cytometry (30) to evaluate the functional consequences of the differential vATPase recruitment in D-Mtb-or R-Mtb-containing phagosomes. As a control, we observed that the fluorescence of LysoTracker Red-stained macrophages was reduced using bafilomycin (27) , a specific vATPase inhibitor (not shown). Interestingly, we found that D-Mtb, as well as HK mycobacteria, did not reduce the fluorescence of LysoTracker Red-stained acidic vesicles in infected macrophages (Fig.  5A) . Alternatively, R-Mtb reduced the fluorescence of LysoTracker Red (Fig. 5B) with a time-dependent mechanism (Supplemental Fig. 2A ). Confocal microscopy (Supplemental Fig. 2B ) confirmed data obtained by flow cytometry showing a reduced number of acidic compartments in R-Mtb-infected macrophages, whereas D-Mtb-infected macrophages displayed a LysoTracker Red staining similar to noninfected macrophages, as well as to macrophages treated with HK R-Mtb. Because one of the consequences of vATPase-mediated phagosome acidification is the activation of proteolytic enzymes that can process Ags, we measured the proteolytic capacity of macrophages infected by the two forms of M. tuberculosis by means of the probe DQ-BSA, which acquires fluorescence on proteolysis. The fluorescence of noninfected macrophages (Fig. 5C ) was reduced using chloroquine, which inhibits the activation of proteolytic enzymes by increasing the phagosomal pH. In agreement with the observed capacity of R-Mtb to increase the phagosomal pH, the mean DQ-BSA-dependent fluorescence of R-Mtb-infected macrophages was re- duced and dependent on the MOI (Fig. 5D) . Conversely, macrophages infected with D-Mtb maintained the same level of fluorescence of noninfected APC, indicating that D-Mtb, as well as HK D-Mtb and HK R-Mtb, did not block proteolysis (Fig. 5C) . To confirm the inability of D-Mtb to interfere with Ag processing and presentation, we tested whether D-Mtb-or R-Mtb-infected macrophages differently process a non-M. tuberculosis-related soluble protein internalized by endocytosis. Macrophages infected with D-Mtb or R-Mtb or treated with HK bacteria were pulsed with MP65, a recombinant Candida albicans protein, and the activation of an MP65-specific T cell clone (31) was used as a readout of the capacity of macrophages to process and present this Ag. Fig. 5E shows that whereas R-Mtb reduced the capacity of infected macrophages to present MP65 to specific T cells in an MOIdependent manner, D-Mtb did not significantly interfere with the Ag processing and presentation of the protein. In fact, the activation of MP65-specific TCC cultured with D-Mtb-infected macrophages was similar to the activation of TCC stimulated by noninfected APC or by macrophages treated with HK R-Mtb. Taken together, these results suggest that by shifting to dormancy, M. tuberculosis may lose the ability to interfere with the protein processing capacity of macrophages, permitting an efficient Ag presentation and T cell activation.
Discussion
In this study we describe a previously underestimated feature of M. tuberculosis that, by shifting to dormancy, may allow phagosome maturation, thus favoring the Ag processing in infected macrophages and ultimately its recognition by Ag-specific T lymphocytes. R-Mtb is highly adapted to life within macrophages, and it can modulate macrophage defenses and inhibit the processing of its Ags for the MHC class II pathway to promote its intracellular survival (32, 33) . In particular, metabolically active M. tuberculosis is endowed with the capacity to arrest phagosomal maturation (34) (35) (36) (37) . To find a possible explanation for the increased Ag presentation capacity of D-Mtb-infected macrophages, we tested whether D-Mtb shares with R-Mtb the same ability to arrest phagosomal maturation (38) . Phagosome maturation is a highly complex process in which phagosomes harboring engulfed particles interact with other intracellular organelles and get acidified (39) by proton pump vATPase polymerization that reduces the neutral pH to an acidic pH (40) . Our results show that following infection of macrophages, D-Mtb reaches intracellular compartments where it colocalizes with the mature phagosome markers LAMP-1 and vATPase. Moreover, D-Mtb-infected macrophages maintain their capacity to digest proteins in acidic compartments differently from R-Mtb-infected macrophages. These results indicate that D-Mtb is not endowed with the ability to arrest the phagosome maturation that characterizes R-Mtb, showing in this respect analogy with HK M. tuberculosis, BCG, and other M. tuberculosis mutant strains (41) .
An important difference with M. tuberculosis that makes BCG an attenuated vaccine strain resides in its lack of the region of difference-1. Region of difference-1 is part of a 15-gene locus known as ESX-1 that encodes a specialized secretion system dedicated to the secretion of CFP-10 and ESAT-6 (42). Interestingly, following infection of DC, the Mtb strain lacking ESAT-6 and CFP-10 localized to LAMP-1 + phagolysomes (43) , suggesting the pivotal role of these proteins in the inhibition of phagosome maturation. In addition to products of the ESX-1 gene, M. tuberculosis uses a range of lipids, such as lipoarabinomannan, and protein effectors to alter the phosphatidylinositol 3-phosphate signaling (44, 45) involved in phagosome maturation. In particular, M. tuberculosis produces the phosphatase SapM, which specifically hydrolyses phosphatidylinositol 3-phosphate (35) . We show that D-Mtb downmodulates expression of the esat6 gene, suggesting that in dormancy M. tuberculosis secretes reduced amounts of ESAT-6 in comparison with R-Mtb. Moreover, expression of the gene Rv3309c, which encodes for SapM, was previously found downregulated in D-Mtb obtained with the same Wayne culture method we used and in stressed mouse macrophages (46) . Taken together, these data are highly suggestive for the pivotal role played by the reduced expression of esat6 and SapM as a possible mechanism used by D-Mtb to permit phagosome maturation and downstream events leading to an increased Ag processing and presentation to specific CD4 + T lymphocytes. D-Mtb is currently thought to represent the mycobacterial stage that resists eradication and persists in LTBI (4, 47) . In this light, it may be considered unexpected that D-Mtb is recognized by T lymphocytes with higher efficiency than R-Mtb. Because the M. tuberculosis-specific T lymphocytes that expanded during primary infection still persist in LTBI, our results would favor the hypothesis that D-Mtb is easily killed by host macrophages upon specific T cell help (48) . This apparent incoherence may be explained considering that it is highly improbable that D-Mtb could infect tissue macrophages in LTBI, as dormant bacteria do not replicate and cannot invade host cells unless they resuscitate as "scout mycobacteria" to sense the environment, but in this case they would lose the characteristics of dormant bacteria (4, 47) . Even though the physical location of bacilli during LTBI remains poorly understood (9, 49, 50), it is conceivable that dormant bacteria reside in cells, which have a scarce ability to act as APC, but behave as an M. tuberculosis reservoir instead. It may be thought that R-Mtb shifts to dormancy within infected macrophages after having subverted their antimicrobial and APC potential (11) . Additionally, M. tuberculosis may reside within subverted or foamy macrophages in mature granulomas (51, 52) , where T cells are physically separated from infected cells by a fibrous wall or caseum that limits APC/lymphocyte interactions (4). Lastly, M. tuberculosis may rest dormant in non-APC, representing sites of immunoprivilege (14) for M. tuberculosis persistence in LTBI.
Recent findings indicate that bacteria with features of dormant, lipid body-positive M. tuberculosis cells are found in sputa from patients with active TB with frequencies ranging from 3 to 86% (19) . Because bacteria in sputa reasonably reflect the population of M. tuberculosis in active pulmonary foci, these findings indicate that a large population of D-Mtb is present in active TB lesions. Irrespective of the stimuli that force M. tuberculosis to switch to a dormant phenotype, it follows that during active TB the immune system is faced not only with R-Mtb, but also with D-Mtb. Therefore, our in vitro model fits with the in vivo scenario of active TB, where replicating, dormant, or both stages of M. tuberculosis challenge the immune system. This model suggests that D-Mtb may represent the form of M. tuberculosis that mainly contributes to the stimulation host-specific immune response in TB.
The immune response in TB is extremely complex (53) , and factors driving the double role of the acquired immunity in protecting against M. tuberculosis or in causing the tissue damage are not yet completely understood (54) (55) (56) . We may suppose that the evolution of a "double personality" would allow M. tuberculosis in its replicative form to escape from immunosurveillance to outgrow and colonize, but also to induce a strong immune response that contributes to tissue damage, shifting to dormancy. In fact, cavitation and damage of lung tissue and bronchi caused by immunopathology are necessary for M. tuberculosis to gain access to the environment and to be transmitted to susceptible individuals (10) .
As a final consideration, the variable relative frequency of D-Mtb and R-Mtb found in sputa may also mirror the population of M. tuberculosis present in infecting droplets released by patients with open TB lesions (19) . Accordingly, the outcome of a primary infection would be probably different in dependence of both the number of mycobacteria and the relative frequency of D-Mtb and R-Mtb in infecting droplets. Interesting in this view is our observation indicating that DC, which are considered the APC involved in the priming of Ag-specific T cells, when infected by DMtb undergo maturation and present a higher amount of Ag than do R-Mtb-infected DC.
In conclusion, the capacity of Mtb to switch to a nonreplicating form of dormancy may represent not only a mechanism of survival in hostile environmental conditions, but also a strategy to modulate and subjugate the host adaptive immune system in the different stages of TB.
